- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome
Total 7102 results
-
Fox Chase Cancer CenterM.D. Anderson Cancer Center; Teva Pharmaceuticals USACompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Thomas Jefferson UniversityAbbVieRecruitingMyelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic SyndromeUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Myeloproliferative Disorders | Myelodysplastic Syndrome | Multiple MyleomaUnited States
-
Daiichi Sankyo, Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
European Society for Blood and Marrow TransplantationHoffmann-La Roche; AmgenCompletedAcute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous LeukemiaGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Plasma Cell Neoplasm | Myeloproliferative NeoplasmsUnited States
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
Rigel PharmaceuticalsRecruitingLow Risk Myelodysplastic SyndromesUnited States
-
Bristol-Myers SquibbActive, not recruitingLower-risk Myelodysplastic SyndromesJapan
-
Everett MeyerNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloid Leukemia, Chronic | Myeloproliferative SyndromeUnited States
-
University Hospital, BrestRecruitingMyelodysplastic Syndromes | Myelodysplastic Syndrome With Isolated Del(5Q) | Myelodysplastic Syndrome With Del(5Q)France
-
Sociedad de Lucha Contra el Cáncer del EcuadorCompletedMyeloproliferative Disorders | Myeloproliferative Neoplasm | Myeloproliferative Syndrome | Myeloproliferative Neoplasm, Unclassifiable | Myeloproliferative Disease, Not ClassifiedEcuador
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Amphivena Therapeutics, Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
CelgeneCompletedMyelodysplastic Syndrome (MDS)China
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)Germany
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Chronic Myelomonocytic Leukemia-0United States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Groupe Francophone des MyelodysplasiesBristol-Myers Squibb; AbbVieRecruitingUntreated Myelodysplastic SyndromeFrance
-
Case Comprehensive Cancer CenterRecruitingMyelodysplastic Syndrome (MDS)United States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)France, Spain, Belgium, Italy, Greece, Hungary, Germany
-
Weill Medical College of Cornell UniversityNovartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)United States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Chinese Society of HematologyHarbin Institute of Hematology & OncologyUnknownMyelodysplastic Syndrome (MDS)
-
Asociación Andaluza de Hematología y HemoterapiaCompleted
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host DiseaseUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Groupe Francophone des MyelodysplasiesUnknownAnemia in Myelodysplastic SyndromesFrance
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMyelodysplastic Syndromes | Secondary Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia-2China
-
Rigshospitalet, DenmarkOdense University Hospital; University of Copenhagen; Imperial College London; University... and other collaboratorsActive, not recruitingMyelodysplastic Syndromes | Cytopenia | Chronic Myelomonocytic Leukemia-1Denmark, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHigh Risk Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLeukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic SyndromeUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Psychosocial Effects...United States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host...United States
-
Alaunos TherapeuticsCompletedLymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)United States
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome-Refractory Anemia With Excess BlastsUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMyelodysplastic Syndrome (MDS)Japan